According to its most recent Form 13F filing with the Securities and Exchange Commission (SEC), Banque Pictet & Cie SA reduced its position in Bed Bath & Beyond Inc. by 11.9% during 4Q.
UPDATE: Banque Pictet & Cie SA’s holdings in Bed Bath & Beyond were worth $3,175,000 as of its most recent filing with the SEC. The firm is believed to own approx. 65,796 shares of the retailer’s stock — after selling 8,865 shares during the period.
Many other institutional investors have been modifying their holdings of the stock. Let’s have a brief look:
Sanders Capital LLC: It raised its position in shares of Bed Bath & Beyond by 1.3% in the 4Q. It now owns approx. 1,719,040 shares of the retailer’s stock worth $85,237,000 after buying an additional 22,000 shares during the last Q.
Investment Management LLC: It raised its position in shares of Bed Bath & Beyond by 10.0% in the fourth quarter. Confluence Investment Management LLC now owns 495,915 shares of the retailer’s stock worth $23,928,000 after buying an additional 45,014 shares during the last quarter.
Russell Frank Co: It raised its position in shares of Bed Bath & Beyond by 22.5% in 4Q. It now owns 487,757 shares of the retailer’s stock worth US$ 23,722,000 after buying an additional 89,548 shares during the last Q.
Thompson Siegel & Walmsley LLC: It raised its position in shares of Bed Bath & Beyond by 15.6% in 4Q. It now owns 519,383 shares of the retailer’s stock worth US$ 25,060,000 after buying an additional 70,242 shares during the last Q.
PGGM Investments: It raised its position in shares of Bed Bath & Beyond by 0.4% in 4Q. It now owns 412,581 shares of the retailer’s stock worth US$ 19,907,000 after buying an additional 1,585 shares during the last Q.
[Exclusive from MarketWatch: TUESDAY: Shares of Bed Bath & Beyond Inc. OPENED at 47.95. It has a 12 month low of US$ 41.26 and a 12 month high of US$ 78.10. The stock has a 50 day moving average price of US$ 44.64 and a 200 day moving average price of US$ 53.91. The firm has a market capitalization of US$ 7.69 billion and a P/E ratio of 9.49.]
